|
C5ORF30 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.14399999975967E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.61779999999778E-05 |
| Normal-vs-Stage2 |
3.739600E-01 |
| Normal-vs-Stage3 |
1.73979997075691E-09 |
| Normal-vs-Stage4 |
3.422100E-04 |
| Stage1-vs-Stage2 |
2.175200E-01 |
| Stage1-vs-Stage3 |
3.858400E-02 |
| Stage1-vs-Stage4 |
8.031000E-01 |
| Stage2-vs-Stage3 |
4.571700E-02 |
| Stage2-vs-Stage4 |
2.101800E-01 |
| Stage3-vs-Stage4 |
2.463000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.79459999971598E-07 |
| Normal-vs-AfricanAmerican |
4.440600E-04 |
| Normal-vs-Asian |
2.035700E-02 |
| Caucasian-vs-AfricanAmerican |
6.352400E-01 |
| Caucasian-vs-Asian |
7.884600E-01 |
| AfricanAmerican-vs-Asian |
5.909000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.06929999965644E-07 |
| Normal-vs-Female |
9.77020000000328E-05 |
| Male-vs-Female |
2.213600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.664100E-02 |
| Normal-vs-Age(41-60Yrs) |
5.5568999999922E-05 |
| Normal-vs-Age(61-80Yrs) |
1.321300000523E-07 |
| Normal-vs-Age(81-100Yrs) |
2.816300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.069800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.861800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.270400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.045400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.239000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.153200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.820900E-03 |
| Normal-vs-Grade 2 |
1.004330E-04 |
| Normal-vs-Grade 3 |
9.88310000504811E-08 |
| Normal-vs-Grade 4 |
1.57785999999049E-05 |
| Grade 1-vs-Grade 2 |
3.238600E-01 |
| Grade 1-vs-Grade 3 |
8.323400E-01 |
| Grade 1-vs-Grade 4 |
7.054400E-01 |
| Grade 2-vs-Grade 3 |
2.140000E-01 |
| Grade 2-vs-Grade 4 |
1.158360E-01 |
| Grade 3-vs-Grade 4 |
3.884800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.195800E-03 |
| Normal-vs-ccB subtype |
2.12550000044942E-07 |
| ccA subtype-vs-ccB subtype |
4.017200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.13250000000065E-06 |
| Normal-vs-N1 |
2.19499999999373E-05 |
| N0-vs-N1 |
2.980300E-02 |
|
|
